J-Long Group Ltd financial statements

Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data J-Long Group Ltd files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2022	FY2024	FY2024	FY2025
Revenue	38.3	38.3	28.4	39.1
Cost of revenue	29.4	28.3	21.6	27.8
Gross profit	8.86	10	6.8	11.3
Selling, general and administrative				3.32
Selling and marketing	1.74	2.17	2.07	3.32
General and administrative	1.59	1.64	4.35	5.54
Operating expenses	3.33	3.81	6.42	8.86
Operating income	5.53	6.23	0.38	2.4
Interest income	0.03	0.02	0.01
Other non-operating income	-0.17	1.52	0.53	0.77
Pre-tax income	5.36	7.75	0.91	3.17
Income tax	0.88	1.1	0.13	0.66
Net income	4.48	6.66	0.78	2.59
EBITDA	5.73	6.4	0.53	2.62
EPS, basic	1.53	2.24	0.26	0.80
EPS, diluted	1.53	2.24	0.26	0.80
Shares, basic (weighted)	2.95	3	3.02	3.26
Shares, diluted (weighted)	2.95	3	3.02	3.26

Balance sheet

	FY2022	FY2024	FY2024	FY2025
Cash and equivalents	7.36	5.96	4.16	10.7
Short-term investments		0.24	0	0
Receivables		2.09	2.35	3.1
Inventory		5.79	4.45	3.07
Other current assets		0.13	0.63	2.03
Total current assets		16.7	14.3	19
Property, plant and equipment		2.37	2.42	3.22
Lease right-of-use assets		0.45	0.09	0.98
Total assets		20.6	16.9	23.5
Accounts payable		2.86	1.36	1.96
Accrued liabilities		0.2	0.45	0.38
Deferred revenue		0.26	0.36	0.43
Short-term debt		2.64	2.04	1.39
Total current liabilities		7.16	5.34	7.09
Total liabilities		9.26	6.72	8.41
Total debt		2.64	2.04	1.39
Paid-in capital		0.26	4.3	6.19
Retained earnings		11.1	5.87	8.47
Other comprehensive income		-0		-0.02
Shareholders' equity	7.06	11.3	10.2
Minority interests				0.41
Total equity	7.06	11.3	10.2	15
Total liabilities and equity		20.6	16.9	23.5
Shares outstanding		30	3.14	3.76

Cash flow statement

	FY2022	FY2024	FY2024	FY2025
Net income	4.48	6.66	0.78	2.51
Depreciation and amortization	0.2	0.17	0.15	0.22
Stock-based compensation				0.65
Deferred income tax	-0.03	-0.01	-0.01	-0
Change in receivables	-0.05	0.76	-0.25	-0.75
Change in inventory	-0.59	-3.28	1.22	1.2
Cash from operations	5.66	1.96	-1.5	7.23
Capital expenditures	-0.08	-0.05	-0.2	-1.02
Cash from investing	-0.08	2.06	0	-1.02
Stock issued			6.34
Dividends paid			-1.68	-0.4
Cash from financing	-2.18	-5.42	0.7	-0.67
Exchange rate effect				-0.03
Net change in cash	3.4	-1.4	-0.8	5.51
Free cash flow	5.58	1.91	-1.7	6.2
Interest paid	0.08	0.12	0.15	0.1
Income taxes paid	1.21	1.33	1.22	-0.7

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $4.85 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	28.8%	Gross profit / revenue.
Operating margin	6.1%	Operating income / revenue.
EBITDA margin	6.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	8.1%	Pre-tax income / revenue.
Net margin	6.6%	Net income / revenue.
FCF margin	15.9%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	18.5%	Cash from operations / revenue.
Effective tax rate	20.7%	Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)	12.9%	Net income / average total assets.
SG&A / revenue	8.5%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.7%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.6%	Capital expenditures / revenue.
D&A / revenue	0.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	37.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	0.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y	65.6%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	8.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income growth, 1y	530.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-24.3%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	396.1%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-23.0%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	230.9%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-16.7%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	207.7%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-19.4%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 3y	8.5%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 3y	3.6%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y	38.8%	Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y	7.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	3.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.68x	Current assets / current liabilities.
Quick ratio	1.94x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.51x	(Cash + short-term investments) / current liabilities.
Debt / assets	5.9%	Total debt / total assets.
Liabilities / assets	35.9%	Total liabilities / total assets.
Net debt	-$9.3M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-3.54x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$11.9M	Current assets - current liabilities.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.94x	Revenue / average total assets.
Fixed asset turnover	13.8x	Revenue / average property, plant and equipment.
Inventory turnover	7.40x	Cost of revenue / average inventory.
Days inventory	49 days	365 x average inventory / cost of revenue.
Receivables turnover	14.3x	Revenue / average receivables.
Days sales outstanding	25 days	365 x average receivables / revenue.
Days payables	22 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	53 days	Days inventory + days sales outstanding - days payables.
FCF conversion	239.3%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	14.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.80	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$0.80	Net income per basic share, as reported (split-adjusted).
Revenue per share	$12.00	Revenue / diluted weighted shares.
FCF per share	$1.91	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.22	Cash from operations / diluted weighted shares.
Cash per share	$2.84	(Cash + short-term investments) / shares outstanding.
Payout ratio	15.4%	Dividends paid / net income, when net income is positive.
Dividends / FCF	6.5%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$17.3M	Share price x shares outstanding.
Enterprise value	$8.0M	Market cap + total debt - cash - short-term investments.
P/E	6.67x	Market cap / net income. Only when net income is positive.
P/S	0.44x	Market cap / revenue.
P/FCF	2.79x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	2.39x	Market cap / cash from operations, when positive.
EV/Sales	0.21x	Enterprise value / revenue.
EV/EBIT	3.34x	Enterprise value / operating income, when both are positive.
EV/EBITDA	3.06x	Enterprise value / EBITDA, when both are positive.
EV/FCF	1.29x	Enterprise value / free cash flow, when both are positive.
FCF yield	35.9%	Free cash flow / market cap.
Earnings yield	15.0%	Net income / market cap (the inverse of P/E).
Dividend yield	2.3%	Dividends paid over the period / market cap.
Shareholder yield	2.3%	(Dividends paid + share buybacks) / market cap.

What was J-Long Group Ltd's revenue in fiscal 2025?

J-Long Group Ltd reported revenue of $39.1M for fiscal 2025, 37.7% higher than the year before.

Was J-Long Group Ltd profitable in fiscal 2025?

Yes. Net income was $2.6M, a net margin of 6.6%.

How much free cash flow did J-Long Group Ltd generate in fiscal 2025?

Cash from operations of $7.2M minus capital expenditures of $1.0M left free cash flow of $6.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to J-Long Group Ltd